Status:
UNKNOWN
Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.
Lead Sponsor:
Beni-Suef University
Collaborating Sponsors:
Cairo University
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
25-40 years
Phase:
PHASE4
Brief Summary
We will compare between Carbitocin and Misoprostol in prevention of postpartum hemorrhage in high risk patients after C.S.
Detailed Description
* Postpartum hemorrhage was traditionally defined as blood loss in excess of 500 mL from a vaginal delivery or 1000 mL at cesarean section. It can result from uterine atony, retained placental tissue ...
Eligibility Criteria
Inclusion
- Women with a singleton pregnancy undergoing cesarean section after 37 weeks of gestation.
- Any medical disorder with pregnancy that carries a risk factor for PPH.
Exclusion
- Women undergoing cesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only.
- women undergoing cesarean section at less than 37 weeks of gestation.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02277067
Start Date
October 1 2014
End Date
August 1 2021
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beni-Suef University
Cairo, Egypt